Prescription Digital Therapeutic for Schizophrenia Receives FDA Breakthrough Device Designation
The device is currently under clinical trial investigation as an adjunct treatment to standard of care therapy for experiential negative symptoms of schizophrenia.
David Benshoof Klein David Mohr Society For Digital Mental Health Us Food Drug Administration Boehringer Ingelheim Drug Administration
Source: psychiatrictimes.com